Gene · 9
Papers1,709
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,709
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Small Molecule Inhibitors of Arylamine N-Acetyltransferase 1 Attenuate Cellular Respiration. | ACS Pharmacol Transl Sci | 2024 | 39144569 | PubTator, text mining | PubMed |
| Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response. | Nat Commun | 2024 | 38992028 | PubTator, text mining | PubMed |
| NAT1 inhibits liver metastasis of colorectal cancer by regulating EMT and glycolysis. | Aging (Albany NY) | 2024 | 38916406 | PubTator, text mining | PubMed |
| Differential expression of NAT1 pharmacogene in hormone receptor positive vs. negative female breast tumors may affect drug treatment. | Pharmacogenet Genomics | 2024 | 38842463 | PubTator, text mining | PubMed |
| Function and expression of N-acetyltransferases 1 and 2 are altered in lymphocytes in type 2 diabetes and obesity. | Biochem Biophys Rep | 2024 | 38737726 | PubTator, text mining | PubMed |
| Contradiction in Star-Allele Nomenclature of Pharmacogenes between Common Haplotypes and Rare Variants. | Genes (Basel) | 2024 | 38674455 | PubTator, text mining | PubMed |
| Downregulation of NAT1 Expression is Associated with Poor Prognosis and Immune Infiltration in COAD. | Pharmgenomics Pers Med | 2024 | 38651072 | PubTator, text mining | PubMed |
| Modifying Effects of Genetic Variations on the Association Between Dietary Isothiocyanate Exposure and Non-muscle Invasive Bladder Cancer Prognosis in the Be-Well Study. | Mol Nutr Food Res | 2024 | 38581346 | PubTator, text mining | PubMed |
| The Arylamine N-Acetyltransferases as Therapeutic Targets in Metabolic Diseases Associated with Mitochondrial Dysfunction. | Pharmacol Rev | 2024 | 38351074 | PubTator, text mining | PubMed |
| Both protein and non-protein components in extracellular vesicles of human seminal plasma improve human sperm function via CatSper-mediated calcium signaling. | Hum Reprod | 2024 | 38335261 | PubTator, text mining | PubMed |
| The role of tryptophan derivatives as anti-kinetoplastid agents. | Heliyon | 2024 | 38187297 | PubTator, text mining | PubMed |
| Loss-of-function cancer-linked mutations in the EIF4G2 non-canonical translation initiation factor. | Life Sci Alliance | 2024 | 38129098 | PubTator, text mining | PubMed |
| Mediator Subunit Med4 Enforces Metastatic Dormancy in Breast Cancer. | bioRxiv | 2024 | 38014033 | PubTator, text mining | PubMed |
| Evaluating possible maternal effect lethality and genetic background effects in Naa10 knockout mice. | bioRxiv | 2024 | 37163119 | PubTator, text mining | PubMed |
| Copy Number Variations in Pancreatic Cancer: From Biological Significance to Clinical Utility. | Int J Mol Sci | 2023 | 38203561 | PubTator, text mining | PubMed |
| Multiomics insights on the onset, progression, and metastatic evolution of breast cancer. | Front Oncol | 2023 | 38169859 | PubTator, text mining | PubMed |
| Virus-Host Protein Interaction Network of the Hepatitis E Virus ORF2-4 by Mammalian Two-Hybrid Assays. | Viruses | 2023 | 38140653 | PubTator, text mining | PubMed |
| The Roles of eIF4G2 in Leaky Scanning and Reinitiation on the Human Dual-Coding POLG mRNA. | Int J Mol Sci | 2023 | 38138978 | PubTator, text mining | PubMed |
| Identification of IncA Plasmid, Harboring blaVIM-1 Gene, in S. enterica Goldcoast ST358 and C. freundii ST62 Isolated in a Hospitalized Patient. | Antibiotics (Basel) | 2023 | 38136693 | PubTator, text mining | PubMed |
| Chromosome 8p engineering reveals increased metastatic potential targetable by patient-specific synthetic lethality in liver cancer. | Sci Adv | 2023 | 38134284 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9/papers?page=3